LEXTF - Lexston Life Sciences Corp.

From OTC Wiki



Jump to: Wiki | News | Links | FAQs | Opinions

Create Wiki page
Become Wiki Editor
Learn to edit


Create News


Lexston Life Sciences is Granted Section 56 Exemption from Health Canada and embarks on the development of portable technology for quantification and traceability of Psilocybe mushrooms
Mon, 00:00 January 31, 2022 | WikiVisor


Lexston Announces The Launch Of A Psychedelic Mushrooms Genetic Identification Test
Mon, 00:00 January 24, 2022 | WikiVisor


Lexston Announces Federal Funding for Cannabis Transformation Project That Will Result in Zero THC Varieties.
Wed, 00:00 January 19, 2022 | WikiVisor


Lexston Comments On Recent Market Activity
Fri, 00:00 January 14, 2022 | WikiVisor


Lexston Announces a Memorandum Of Understanding to Collabborate on Psychedelics Research and Development with Alvarius Research Inc.
Wed, 00:00 January 12, 2022 | WikiVisor

More News: Company News | OTC Markets

LEXTF Stock
LEXTF Profile by TradingView
Lexston Life Sciences Corp. by TradingView

Edit Links page


Create FAQs page


No opinions so far.

Please login or register to post your opinion.



Retrieved from "https://otcwiki.net/w/index.php?title=LEXTF_-_Lexston_Life_Sciences&oldid=126085"
Powered by MediaWiki
Powered by Semantic MediaWiki
© 2023 OTC Wiki